Your browser doesn't support javascript.
loading
Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Dossenbach, Martin; Arango-Dávila, Cesar; Silva Ibarra, Hernan; Landa, Eric; Aguilar, Jaime; Caro, Osvaldo; Leadbetter, Joanna; Assunção, Sheila.
Affiliation
  • Dossenbach M; Eli Lilly and Company, Ges.m.b.H, Vienna, Austria. d.m@lilly.com
J Clin Psychiatry ; 66(8): 1021-30, 2005 Aug.
Article in En | MEDLINE | ID: mdl-16086618
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Ambulatory Care Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Psychiatry Year: 2005 Document type: Article Affiliation country: Austria
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Ambulatory Care Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Psychiatry Year: 2005 Document type: Article Affiliation country: Austria